VAERS Explorer
Back to explore

Report #2843912

Received Jun 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
51 yrs
State
NC
Recovered
Not recovered
Vaccinated
Mar 28, 2025
Onset
Mar 28, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

HypoaesthesiaParaesthesia oral

Symptom narrative

Tingling tongue; numbness in arm; This non-serious case was reported by a other health professional via patient support programs and described the occurrence of tingling tongue in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 28-MAR-2025, the patient received Shingrix. On 28-MAR-2025, less than a day after receiving Shingrix, the patient experienced tingling tongue (Verbatim: Tingling tongue) and numbness of upper extremities (Verbatim: numbness in arm). The outcome of the tingling tongue and numbness of upper extremities were resolving. The reporter considered the tingling tongue and numbness of upper extremities to be related to Shingrix. The company considered the tingling tongue and numbness of upper extremities to be related to Shingrix. Additional Information: GSK Receipt Date: 29-MAY-2025 The weight of the patient was reported as 80.29 kgs. Healthcare professional reported that patient had an allergic reaction to Shingrix vaccine. Patient experienced a tingling tongue and numbness in her arm. No other information was provided.